Jim Easton Consortium - Project 5: Imaging and Genetic Biomarkers for Alzheimer’s Disease (ImaGene)

This four-year research study will investigate the correlation between genes, proteins and brain imaging in aging and the development of Alzheimer's disease. Normal control subjects and persons with mild cognitive impairment who are age 50 and older may qualify. For more information about this study, please click Imaging and Genetic Biomarkers for Alzheimer’s Disease (ImaGene).